Aerami Therapeutics is based in Deerfield, IL. It has raised $250M in total funding. Latest round: IPO.
Aerami Therapeutics funding overview
Aerami Therapeutics is based in Deerfield, IL. Aerami Therapeutics has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in December 2021. The round record for Aerami Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Panakes Partners, Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital, IP Group. 6 distinct backers are named across the disclosed rounds.
Aerami Therapeutics at a glance
Total raised
$250M
Latest round
IPO
Latest round date
December 2021
Headquarters
Deerfield, IL
Notable investors
Panakes Partners, Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital, IP Group
Frequently asked about Aerami Therapeutics funding
How much has Aerami Therapeutics raised?
Aerami Therapeutics has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Aerami Therapeutics?
Panakes Partners, Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital, IP Group are named among the investors backing Aerami Therapeutics.
What was the latest Aerami Therapeutics funding round?
The most recent disclosed round is an IPO, announced in December 2021.
Where is Aerami Therapeutics based?
Aerami Therapeutics is based in Deerfield, IL.
When did Aerami Therapeutics last raise?
The last disclosed Aerami Therapeutics round closed in December 2021 at IPO.
Totals shown for Aerami Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Deerfield and the investors behind them below.
